Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway

The use of mesenchymal stem cells (MSCs) has become a new strategy for treating diabetic kidney disease (DKD). However, the role of placenta derived mesenchymal stem cells (P-MSCs) in DKD remains unclear. This study aims to investigate the therapeutic application and molecular mechanism of P-MSCs on...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiudan, Wang, Jiao, Li, Ruilin, Huang, Meiling, Yue, Guanru, Guan, Lulu, Deng, Yuanyuan, Cai, Wei, Xu, Jixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003373/
https://www.ncbi.nlm.nih.gov/pubmed/36902127
http://dx.doi.org/10.3390/ijms24054696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003373/
https://www.ncbi.nlm.nih.gov/pubmed/36902127
http://dx.doi.org/10.3390/ijms24054696

Ejemplares similares